mRNA encoding anti-HIV-1 antibody VRC01 (Acuitas Therapeutics)

N/A

Report date: 2025/11/19 10:17:03

Base Information

Drug NamemRNA encoding anti-HIV-1 antibody VRC01 (Acuitas Therapeutics)
Drug Alias NameVRC01 mRNA-LNP (Acuitas Therapeutics)VRC01 mRNA-LNP
ClassificationSmall molecules > LipidBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHIV envelope protein gp120 inhibitors
TargetsHIV envelope protein gp120
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcuitas Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcuitas Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A